Trials / Unknown

UnknownNCT01833052

CLaret Embolic Protection ANd TAVI - Trial

Status: Unknown
Phase: N/A
Study type: Interventional
Enrollment: 100 (estimated)

Sponsor: University of Leipzig · Academic / Other
Sex: All
Age: 18 Years
Healthy volunteers: Not accepted

Summary

This prospective, randomized study was designed to investigate the benefit of using a Filter-Protection-Device (Claret MontageTM Dual Filter System) during transcatheter aortic valve implantation (TAVI) with a Medtronic CoreValve®.

Conditions

Frequency of Cerebral Perfusion Defects After TAVI
Size of Cerebral Perfusion Defects After TAVI

Interventions

Type	Name	Description
DEVICE	TAVI (Medtronic CoreValve)
DEVICE	Claret-Filter

Timeline

Start date: 2013-04-01
Primary completion: 2014-06-01
Completion: 2015-06-01
First posted: 2013-04-16
Last updated: 2015-05-05

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT01833052. Inclusion in this directory is not an endorsement.